IRIS
SILINI, ENRICO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.371
EU - Europa 1.078
AS - Asia 823
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 3.278
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.358
CN - Cina 786
IE - Irlanda 341
UA - Ucraina 200
FI - Finlandia 160
DE - Germania 151
SE - Svezia 76
IT - Italia 52
GB - Regno Unito 45
FR - Francia 32
JP - Giappone 17
CA - Canada 13
SG - Singapore 11
CZ - Repubblica Ceca 9
VN - Vietnam 6
BE - Belgio 5
EU - Europa 3
AU - Australia 2
CH - Svizzera 2
IN - India 2
NL - Olanda 2
IR - Iran 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
RO - Romania 1
RU - Federazione Russa 1
Totale 3.278
Salva come PNG Salva come JPEG
Città #
Dublin 341
Chandler 335
Jacksonville 295
Nanjing 238
Ashburn 96
Nanchang 88
Beijing 83
Princeton 69
Hebei 68
Lawrence 63
Shenyang 60
Wilmington 59
Jiaxing 51
Changsha 46
Tianjin 45
Hangzhou 39
Medford 37
Boardman 33
Helsinki 29
Ann Arbor 23
Milan 23
Shanghai 19
Verona 17
Tokyo 16
Norwalk 15
Woodbridge 12
Munich 11
Toronto 11
Brno 8
Des Moines 8
Auburn Hills 7
Jinan 7
Kunming 7
Dearborn 6
Dong Ket 6
Singapore 6
Brussels 5
Guangzhou 5
Falls Church 4
New York 4
Zhengzhou 4
Berlin 3
Changchun 3
Los Angeles 3
Washington 3
Basel 2
Borås 2
Costa Mesa 2
Houston 2
Lodi 2
London 2
Ningbo 2
Orange 2
Seattle 2
Taizhou 2
Adelaide 1
Billings 1
Bristol 1
Comazzo 1
Corbetta 1
Fairfield 1
Falkenstein 1
Gunzenhausen 1
Haikou 1
Hamilton 1
Hefei 1
Lanzhou 1
Las Vegas 1
Liverpool 1
Monmouth Junction 1
Nuremberg 1
Piacenza 1
Redwood City 1
Rockville 1
San Francisco 1
San Jose 1
Terrebonne 1
Wetaskiwin 1
Zanjan 1
Totale 2.355
Salva come PNG Salva come JPEG
Nome #
Cross-reactive antibodies to hypervariable region 1 (HVR1) of the hepatitis C virus E2/gp70 glycoprotein 85
GB virus C infection in patients treated for childhood acute lymphoblastic leukemia 76
Su di uno "strano" epatocarcinoma 75
Multiple human papillomavirus infection with or without type 16 and risk of cervical intraepithelial neoplasia among women with cervical cytological abnormalities. 74
Untypable human papillomavirus infection and risk of cervical intraepithelial neoplasia among women with abnormal cervical cytology 71
Antibody responses to the hepatitis C virus (HCV) E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects. 66
Diagnostic accuracy of colposcopy in relation to human papillomavirus genotypes and multiple infection 66
Codon 72 polymorphisms of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients 65
Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. 65
Molecular epidemiology of hepatitis C virus infection in intravenous drug users. 64
The impact of viral genotype on the natural history of HCV-induced cirrhosis: a prospective study 64
Is the natural history of hepatitis C virus carriers with normal aminotransferase really bening? 63
Clinical significance of hepatitis C virus genotypes. 63
HLA class II alleles confer protection or susceptibility to chronic hepatitis C 62
Antibody-negative chronic hepatitis C virus infection in immunocompetent children 61
Low prevalence of antibodies to the HCV envelope region in anti-HCV seronegative, HCV RNA positive patients 61
HCV viremia in hemodialysis patients 60
CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. 59
HCV genotype 1b is a major risk factor for the development of hepatocellular carcinoma (HCC) in cirrhotic patients: a prospective study 59
Epidemiology of HCV genotypes and risk of cirrhosis in apulia: a population-based case-control study 58
In vitro T-cell immune reactivity against promiscuous frames of hepatitis C virus core protein predicted by computational analysis 58
Cathepsin E in antigen-presenting Langerhans and interdigitating reticulum cells. Its possible role in antigen processing. 58
Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitis. 57
Association between class II allelles and protection or susceptibility to chronic hepatitis C 56
Evaluation of the HPV typing INNO-LiPA EXTRA assay on formalin-fixed paraffin-embedded cervical biopsy samples 56
Comparative evaluation of two serologic typing methods of hepatitis C virus 55
HCV genotypes in the development of hepatocellular carcinoma (HCC) in anti-HCV positive cirrhotic patients: preliminary report of a prospective study 55
Polymporphisms of P450 genes and risk of hepatocellular carcinoma in HCV-infected patients. 54
Modelling liver fibrosis progression in chronic hepatitis C: a study of 563 patients with sequential liver biopsies 53
Comparative evaluation of two serological typing methods for hepatitis C virus 53
Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in Southern Italy: a population-based study. 52
Hepatitis C virus core serotypes in haemodialysis patients 51
Hepatitis C virus (HCV) infection in children treated for acute lymphoblastic leukemia (ALL) 51
Analysis of hepatitis C virus hypervariable region 1 sequence in cryoglobulinaemic patients and associated control 51
In vitro T-cell immune reactivity against promiscuous frames on hepatitis C virus core proteine predicted by computational analysis 50
HLA-DQA1, DQB1 heterodimers in chronic hepatitis C 50
Antibody responses to hepatitis C virus hypervariable regione 1: evidence for cross-reactivity and immune-mediated sequence variation 50
Hypervariable region 1 (HVR1) of HCV: immunological decoy or biologically relevant domain? 49
HLA genes and chronic hepatitis C severity 49
HGV-GBV-C infection in liver transplant recipients. Antibodies to the viral E2 envelope glycoprotein protect from de novo infection 49
Virological features of HCV infection in hemodialysis patients 48
Multiple Papillomavirus Infection and Size of Colposcopic Lesions Among Women With Cervical Intraepithelial Neoplasia 47
Comparative evaluation of HCV core genotyping and serotyping 47
Different spectrum of liver disease in patients with HCV genotype II and III infection 43
Hepatitis C virus infection in children treated for acute lymhoblastic leukemia 43
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study 41
Vertical trasnmission of hepatitis C 40
Placental lesions associated with oligohydramnios in fetal growth restricted (FGR) pregnancies 40
HLA class II and III and severity of hepatitis C virus (HCV)-related chronic liver disease 39
Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients. 38
High prevalence of hepatitis C virus genotype III infection in patient with normal liver enzymes and mild histologic lesions 38
Hepatitis C virus genotypes and risk of cirrhosis in Southern Italy 38
Dynamic of hypervariable region 1 (HVR1) variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease 37
Molecular epidemiology of HCV infection in drug addicts 35
HVR1 variation, viral type and ALT values in chronic HCV infection 35
Genotipi del virus dell'epatite C e rischio di carcinoma epatocellulare: uno studio prospettico 35
Prevalenza di esposizione ad HGV in un day-hospital oncologico pediatrico 35
Virological feaures of hepatitis C virus infection in hemodialysis patients 34
Significance of hepatitis C virus genotypes 34
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study 34
Polymorphysms of glutathione s-trasnferase and epoxide hydrolase and severity of HCV-related liver disease 33
null 30
Hepatitis C virus (HCV) core serotypes in chronic HCV infection 27
Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease. 27
Molecular epidemiology of hepatitis C virus infection among inravenous drug users 25
Phylogenetic analysis of hepatitis G virus (HGV) 5'-non coding regione and development of a rapid PCR-based typing assay 24
Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (E2; gp70) hypervariable regione 1 in hepatitis C viremic patients 21
Totale 3.342
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.840
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020918 262 390 0 38 1 39 8 43 1 88 47 1
2020/2021372 38 32 10 37 1 54 1 59 10 65 48 17
2021/2022234 0 1 12 3 2 12 1 11 18 7 43 124
2022/2023982 125 77 6 69 108 99 0 55 403 8 25 7
2023/2024266 23 55 6 32 27 57 1 23 1 6 9 26
2024/202529 29 0 0 0 0 0 0 0 0 0 0 0
Totale 3.342